Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias

Not Recruiting

Trial ID: NCT03769207

Purpose

This post-marketing study is conducted to characterize the ability of Apple Watch rhythm analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical evaluation among users who contact AppleCare.

Official Title

Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias

Stanford Investigator(s)

Marco Perez
Marco Perez

Associate Professor of Medicine (Cardiovascular Medicine)

Eligibility

Inclusion Criteria:

1. Possession of the following at time of eligibility screening:

* iPhone (5s or later) with iOS version 12.1.1 or later defined as iPhone model/iOS version used to complete screening eligibility.
* Apple Watch (Series 1-4) with watchOS version 5.1.2 or later defined as Apple Watch model/watchOS paired with iPhone used to complete screening eligibility
2. At least one of the following by self-report before consent:

* Irregular Rhythm Notification
* ECG app classification of Atrial Fibrillation
* ECG app classification of Inconclusive defined as "Inconclusive," "Heart Rate Over 120," or "Heart Rate Under 50"
3. Age ≥ 22 years at time of eligibility screening
4. Current resident of the United States at time of eligibility screening, and will reside in the United States for the length of the study
5. Proficient in written and spoken English
6. Valid phone number associated with iPhone, ascertained from self-report
7. Valid email address, ascertained from self-report

Exclusion Criteria:

1. Shared iCloud account
2. Shared AppleWatch

Intervention(s):

device: Ambulatory ECG

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
SCCR
650-723-9363